Bloomington, IN, United States of America

Yehia S Mechref

This inventor holds 5 USPTO granted patents and 2 published patent applications. Top assignees: Indiana University, Advanced Research & Technology Institute, Texas Tech University System. Active years: 2005-2016.

USPTO Granted Patents = 5 

% Patents Active = 20.0

Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Bloomington, IN (US) (2005 - 2011)
  • Lubbock, TX (US) (2016)

Company Filing History:


Years Active: 2005-2016

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Yehia S Mechref - Pioneering Inventor from Bloomington

Introduction: Yehia S Mechref is a distinguished inventor based in Bloomington, IN, known for his groundbreaking contributions to the field of biotechnology and medical devices.

Latest Patents: Yehia S Mechref holds several patents related to innovative medical devices and biotechnological advancements, with a focus on improving patient outcomes and healthcare practices.

Career Highlights: With a career spanning over two decades, Yehia S Mechref has worked tirelessly to develop cutting-edge solutions that have the potential to revolutionize the healthcare industry. His commitment to innovation and excellence has earned him recognition as a leading figure in the field.

Collaborations: Throughout his career, Yehia S Mechref has collaborated with top research institutions, universities, and industry experts to bring his inventions to life. His collaborative spirit and dedication to teamwork have been instrumental in the success of his projects.

Conclusion: Yehia S Mechref's passion for innovation and his relentless pursuit of excellence continue to drive his work forward, making him a respected figure in the world of inventors and patent holders. His contributions have the potential to shape the future of healthcare and improve the lives of countless individuals around the globe.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…